2 mg semaglutide to tirzepatide Ozempic® (semaglutide) and Mounjaro™ (tirzepatide), a major breakthrough for the treatment of obesity Addressing the Weight Loss Injectable

Off-label use simply means a provider is using a substance for a purpose other than its original intention, based on professional judgment and clinical evidence

Emotional eating and evening grazing are two of the hardest patterns to break through willpower alone, and when the drug turns down the volume on both, women often find they are making better choices without feeling deprived

2005;289(6):H24018

Further Research Resources Additional research articles, comparison guides, and laboratory protocols related to this peptide:

Groups that should avoid or seek clinician guidance first Pregnancy and breastfeeding: GHK-Cu has not been adequately studied in pregnancy or lactation